PPA
PLRX icon

Parametric Portfolio Associates’s Pliant Therapeutics PLRX Stock Holding History

Parametric Portfolio Associates’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$137K Buy
19,500
+8,180
+72% +$83.5K ﹤0.01% 3513
2021
Q4 		$153K Buy
+11,320
New +$180K ﹤0.01% 3477

Other funds holding PLRX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return

Parametric Portfolio Associates's PLRX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Pliant Therapeutics (PLRX) stake by 72% in Q1 2022, buying an estimated $83.5K and bringing the position to 19,500 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

Parametric Portfolio Associates first reported a position in PLRX in Q4 2021 and has held it in 2 quarters since. The position peaked at $153K in Q4 2021. 92 funds tracked by Wall St. Rank hold PLRX as of Q1 2022.

  • Parametric Portfolio Associates held 19,500 shares of Pliant Therapeutics worth $137K as of Q1 2022.
  • Parametric Portfolio Associates bought 8,180 Pliant Therapeutics shares in Q1 2022, an estimated $83.5K.
  • Pliant Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3513 holding.
  • Parametric Portfolio Associates first reported a position in Pliant Therapeutics in Q4 2021 and has held it in 2 quarters since.
  • Parametric Portfolio Associates's Pliant Therapeutics position peaked at $153K in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.